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ABSTRACT: Magnetic hyperthermia is a new type of cancer treatment designed for overcoming 
resistance to chemotherapy during the treatment of solid, inaccessible human tumors. The main 
challenge of this technology is increasing the local tumoral temperature with minimal side 
effects on the surrounding healthy tissue. This work consists of an in vitro study that compared 
the effect of hyperthermia in response to the application of exogenous heating (EHT) sources 
with the corresponding effect produced by magnetic hyperthermia (MHT) at the same target 
temperatures. Human neuroblastoma SH-SY5Y cells were loaded with magnetic nanoparticles 
(MNPs) and packed into dense pellets to generate an environment that is crudely similar to that 
expected in solid micro-tumors, and the above-mentioned protocols were applied to these cells. 
These experiments showed that for the same target temperatures, MHT induces a decrease in cell 
viability that is larger than the corresponding EHT, up to a maximum difference of 
approximately 45% at T = 46°C. An analysis of the data in terms of temperature efficiency 
demonstrated that MHT requires an average temperature that is 6°C lower than that required with 
EHT to produce a similar cytotoxic effect. An analysis of electron microscopy images of the 
cells after the EHT and MHT treatments indicated that the enhanced effectiveness observed with 
MHT is associated with local cell destruction triggered by the magnetic nano-heaters. The 
present study is an essential step toward the development of innovative adjuvant anti-cancer 
therapies based on local hyperthermia treatments using magnetic particles as nano-heaters. 
KEYWORDS: magnetic nanoparticles; magnetic hyperthermia; human neuroblastoma; specific 
power absorption; cell viability.  
The use of heat as a therapeutic tool in oncology dates back to the beginning of the previous 
century.1 The biological effects of hyperthermia are two-fold: concomitant with the sensitizing 
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effect of heat on tumor cells, which can improve the therapeutic effect of radiation, hyperthermia 
also produces a direct cytotoxic effect. As a result, an adequate heat treatment can practically kill 
tumor cells within a nutritionally deficient, hypoxic and acidic environment.2 Although the 
therapeutic uses of heat on tumor cells have remained essentially unchanged, the methods for 
heat generation and delivery have experienced impressive advances. From the first protocols 
using water baths, heat delivery has evolved to precise, non-contact methods, including 
radiofrequency, microwaves, and focused ultrasound waves. The use of magnetic nanoparticles 
(MNPs) as nano-heaters is the most recent of such developments in the delivery of heat to tumor 
cells and is known as magnetic hyperthermia (MHT) or thermotherapy. The MHT protocol is 
based on the application of an alternating magnetic field (AMF) to the applied MNPs, which 
results in the coupling of the magnetic moments of the MNPs with the oscillating field and the 
conversion of the absorbed energy into heat within the target tumor. The remote, contactless 
action of the AMF to produce heat locally in the body makes MHT an interesting treatment for 
eliminating non-accessible, deep tumors that often cannot be treated with surgery. The sublethal 
heating of cancer cells has been well recognized for many years as a coadjutant therapy to radio- 
or chemotherapy.3-5  
The frequencies used for MHT are in the low radiofrequency range, i.e., at the approximately 
100-kHz range. The physical mechanism underlying the observed heat generation is the 
interaction between the magnetic moments of the MNPs and the magnetic component of the 
applied electromagnetic waves, and the direct interaction of both components with living matter 
is almost negligible; thus, heat production is only observed in the area where the nano-heaters are 
delivered in the target region of interest.6 The rationale behind the use of hyperthermia as a 
coadjutant protocol for radio- or chemo-therapy is that cancer cells are more sensitive to 
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radiation when they have been previously subjected to high temperatures of 42-45°C, and thus, 
the use of these two therapies results in a synergistic effect.2,7  
The physiological effects of temperature on living organisms are well understood.8 The 
exposure of mammalian cells to elevated temperatures produces a dose-dependent effect that 
triggers a cascade of cellular events that compromise and/or damage the cells.9 In cancer cells, 
high temperatures also interfere with the regulation of biological processes, such as proliferation 
and metabolism functions,10 and the exposure of tissues to temperatures above 43-45°C induces 
necrosis or apoptosis.11 Hyperthermia also triggers protein denaturation, which affects the 
function of most proteins involved in signaling, membrane, cytoskeleton or DNA maintenance, 
among other functions, and causes cell-growth inhibition and cell apoptosis.12 Mammalian cells 
have short-term thermotolerance mechanisms that could be overridden by resistant cancer cells,13 
such as the expression of a heterogeneous family of proteins labeled heat shock proteins (HSPs). 
These HSPs participate in the process of polypeptide refolding after protein denaturation caused 
by heat stress.  
The neuroblastoma-derived SH-SY5Y cell line is a model of human malignant metastatic 
neuroblastoma characterized by a high resistance to oxidative14 and thermal15 stresses through 
the overexpression of high levels of HSPs. SH-SY5Y cells therefore exhibit a notable resistance 
to hyperthermic stress.16 For this reason, this oncogenic thermo-tolerant cell line was selected as 
an in vitro model for analyzing the effects of magnetic hyperthermia.17  
This manuscript reports the results of a comparative study of two different heating treatments: 
heating using an exogenous source, specifically immersion in a water bath (EHT), and local 
intra-tumoral heating produced by magnetic hyperthermia (MHT). An empirical analysis of the 
different cellular responses to these two treatments, which focused on the comparison of the 
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cytotoxic effects triggered by MNP-based hyperthermia with the effects induced by exogenous 
hyperthermia, is then presented.  
RESULTS AND DISCUSSION 
Heating treatments: exogenous hyperthermia (EHT) and magnetic hyperthermia (MHT). 
This experiment aimed to compare the effects of EHT- and MHT-induced hyperthermia on 
human neuroblastoma cells. To determine the latent mechanisms of cell death induced by 
hyperthermia, we produced MHT using in-house synthesized PEI-MNPs as nano-heaters (see 
Figure 1). Dense cell pellets (see Methods), which roughly simulate a “micro-tumor” 
environment and thus present conditions that resemble some of the intra-tumoral conditions 
observed during in vivo experiments, were used in two comparative analyses, namely immediate 
(to) and long-term (t = 6 hours) cell viability assays.  
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Figure 1. Scheme of the thermotherapy assays: the left column represents the three control 
samples, and the right column presents the experimental treatments with exogenous (EHT) and 
the local magnetic hyperthermia (AMF). 
Exogenous hyperthermia (EHT). To investigate the effect of hyperthermia produced by 
‘exogenous heating’ on a set of compacted neuroblastoma cell pellets, these pellets were 
exogenously heated in a water bath at different target temperatures up to 56°C for 30 minutes 
and were then allowed to recover in cultures plates immediately after each treatment for 6 hours 
before their cell viability was measured. The latter analysis aimed to assess any long-term heat-
induced cytotoxic effects. These hyperthermia-treated cells were compared with (i) cells treated 
with AMF, (ii) cells incubated with MNPs but not treated with AMF, and (iii) cells maintained at 
sub-hyperthermic temperatures (experimental controls).  
The control cell samples were maintained at sub-hyperthermic temperatures of 37°C and 40°C 
and presented viability levels of 97 and 93%, respectively. These results confirmed that sample 
manipulation induced minor or no effects on cell viability (SI, Figure S1). The viability of cells 
exposed to mild-temperature hyperthermia (T = 42°C) and then maintained for 6 hours at 37°C 
in CO2 conditions was also tested, and no changes in cell viability or proliferation were detected. 
These data allowed us to discard the existence of any ‘latent’ effect on cell physiology. 
Incubation of the cells at 43°C resulted in a significant decrease in cell viability to 87% 
(normalized to the control samples and measured immediately after the hyperthermia treatment), 
and a viability of 78% was obtained 6 hours after the heating experiment. These divergences 
between to and t6h increased with increasing temperature and reached a maximum difference of 
22% with a temperature of 52°C, as shown in the inset of Figure S1 in the SI. For target 
temperatures above 52°C, a massive cytotoxic effect, with an overall cell viability less than 20%, 
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was observed; thus, no further differences were detected between the early and long-term 
cytotoxic effects. 
In all cases, the viability data as a function of temperature could be fitted by a sigmoidal-type 
equation: 
𝐂(𝑻) =
𝑨
𝟏+𝒆𝑩∙(𝑻−𝑻𝒐)
  Eq. 1 
which is a simplified expression based on the two-state model of cell damage developed by Feng 
et al.18 for constant exposure times. A more in-depth analysis of Eq. 1 within the context of the 
two-state model is beyond the scope of the present work, but it is important to note that the 
phenomenological approach using Eq. 1 allows a straightforward comparison of the parameters 
that characterize the temperature behaviors obtained with both the EHT and MHT protocols used 
in this study. The parameter A represents the viability percentage of the control cells (~98%), 
and B quantifies the temperature width for a given decrease in cell viability. Finally, the 
parameter T0 (in °C) determines the temperature at which the cell viability function C(T) 
decreases to 50% of the maximum value. This 50% lethal dose (LD50%) represents the exposure 
required to kill half of the original cell population. We used Eq. 1 to comparatively analyze the 
LD50% of both EHT and MHT as a function of increasing target temperatures. The results for 
EHT showed that it was necessary to reach a temperature of 47.7°C to achieve the long-term 
effect (t6h) of killing 50% of the cells.  
Magnetic hyperthermia (MHT). Using MNPs as nano-heaters to increase the temperature in 
‘micro-tumor-phantoms’ requires not only detailed knowledge of the power absorption profile of 
the MNPs but also thermodynamic considerations regarding heat loss in small-scale biological 
environments.12,19 To determine the minimum number of cells required for attaining the target 
temperatures in the hyperthermia region (T < 42°C), we compared several cell pellets containing 
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various numbers of cells (from 2x106 to 2x107 cells in a 100-L pellet) that were incubated with 
different concentrations (from 10 to 100 g/mL) of PEI-MNPs with a SPA=239±19 W/g in 
water at f = 570 kHz and H = 23.9 kA/m. All the subsequent experiments involved incubation of 
the cells with 100 μg/mL PEI-MNPs.  
To assess the effect of an alternating magnetic field (AMF) on neuroblastoma cells, we 
exposed the control cells (compacted into dense pellets) to identical experimental conditions (f = 
570 kHz; H = 23.9 kA/m; 30 min) in the absence of PEI-MNPs. The cell viabilities at t0 and t6h 
(Supplementary Information, Figure S2) show negligible cytotoxic effects (97 and 94% viable 
cells at to and t6h, respectively). The effects on the cell viability of the magnetically loaded cells 
were investigated by increasing the T from a starting permissive set point of 37°C. At sub-
hyperthermic temperatures of 37 and 40°C, the required amplitude of the AMF was quite small. 
Accordingly, the two corresponding points in the curve showed that the nano-heaters induced 
little or no effect, resulting in high viability percentages (91% and 87% at t0, respectively). 
However, although the differences in cytotoxicity at t0 and t6h were negligible at 37°C, the 
viability of the cells exposed to T = 40°C decreased from 87% (at t0) to 75% at t6h. Increased 
differences between t0 and t6h were obtained at higher target temperatures, and a maximum 
difference in viability of 20-24% was found at temperatures near 46°C (SI, Figure S2 inset). 
Based on the observed differences in cell viability between t0 and t6h, we decided to focus on the 
effects on cell viability at t6h while bearing in mind that the cytotoxic effect of MHT could be 
significantly enhanced depending on the post-treatment time scale. According to Eq. 1, a T0 
value equal to 42.1°C is required for a long-term effect.   
Finally, a comparison between the cell viability curves obtained at t6h after the exogenous and 
localized treatments showed a clear difference in the T0 required to obtain a similar cytotoxic 
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effect on neuroblastoma cells. Figure 2 presents a direct comparison between both tendency 
curves and demonstrates how the L50 of the dense cell pellets treated with MHT was 
substantially lower (i.e., 42.1°C) than that obtained with exogenous hyperthermia. At this 
temperature, 88.8% of the neuroblastoma cells in the EHT experiments were still unaffected. 
Under our experimental conditions, a maximum difference in cytotoxicity of approximately 45% 
was observed at T0 = 46°C. 
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Figure 2. Viability after EHT (solid circles) and MHT (open diamonds) treatments (570 kHz; 30 
min, 100 g/mL, n = 5) as a function of the target temperature. The dashed lines are the trend 
lines predicted using Eq. 1. The difference in the temperatures (T0 = 6°C) needed to induce 
50% cell death is indicated by the dotted line between the EHT and MHT curves. Lower panel: 
curve of the difference between the EHT and MHT viability data, showing that the maximum 
viability difference max = 45% was obtained at T = 45.1°C.  
Qualitative and quantitative evaluation of hyperthermia-induced cell death. In response to 
an external insult, cells die by apoptosis and/or necrosis.20 To evaluate the cytotoxic effects of 
exposure to the heating treatments for 30 minutes in detail, we analyzed the cells by flow 
cytometry (FACS) using a series of cell indicators of death by necrosis and/or apoptosis (see the 
 10 
materials section). In brief, early phases of apoptosis were identified by the presence of Annexin 
V on the surface of cells, whereas late apoptotic cells were identified through simultaneous 
labeling with Annexin V and non-vital dyes. Additionally, necrotic cells were only stained with 
non-vital dyes. Hence, this study allowed us to quantitatively and qualitatively determine the 
type of cell death experienced by these neuroblastoma cells. Figure 3 shows the overall 
percentages of cell death (including apoptotic and necrotic cells) observed in hyperthermia-
treated cells exposed to temperature T0 corresponding to the LD50% identified for the EHT 
protocol. These data have been adapted from the dot plots (see Figure S3 in the supplementary 
Information) that make possible to differentiate between those cells that express each one of the 
fluorescent markers from those that express neither or both. As expected, the MHT treatment 
was found to exert its cytotoxic effect more efficiently than the exogenous hyperthermia 
treatment (approximately 77% versus 57%). Interestingly, this study also revealed that the two 
hyperthermia treatments induced different cell death mechanisms (late apoptosis-necrosis).  
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Figure 3. Quantitative and qualitative flow cytometric analysis of cell death in control and 
hyperthermia-treated SH-SY5Y cells incubated with PEI-MNPs (100 g/mL) at T0 = 42.5°C for 
30 minutes. The viability data are displayed after grouping apoptotic and necrotic death (red 
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bars) and show that exogenous hyperthermia (EHT) is less effective than magnetic hyperthermia 
(MHT). 
An analysis of confocal microscopy projection images of the nuclei of control and 
hyperthermia-treated SH-SY5Y cells (see Figure 4) revealed that the untreated control cells 
display a well-shaped nuclei (A, blue channel) comparable to that of cells exposed to Alexa 488-
labeled MNPs (B, red channel). Occasional mitotic figures were also observed (empty arrows). 
However, irregularly shaped nuclei and occasional compacted chromatin spots indicative of 
pyknosis were observed in the cells exposed to MNPs and EHT (C). In addition, the cells 
exposed to magnetic hyperthermia (D) display aberrant nuclear shapes, and some of the cells 
exhibit some morphological features indicative of karyolysis, pyknosis (blue arrow) and 
karyorrhexis (red arrow).  
 
Figure 4. Confocal microscopy projection images of SH-SY5Y cells exposed to Alexa 488-
labeled MNPs. The nuclei (blue channel) of the untreated cells display a fairly regular circular 
shape that does not differ from that of the nuclei of cells exposed to f-PEI-MNPs (100 g/mL, 
 12 
red channel). In contrast, neuroblastoma cells exposed to hyperthermia show evident nuclear 
morphological shape aberrations, and these aberrations are more pronounced in the cells treated 
with MHT (blue arrow). All images are pseudocolored. 
The effects of temperature, primarily exogenous hyperthermia treatments, on cell viability 
have been previously reported by several researchers. Cheng et al. studied the effect of 
hyperthermia by heating SH-SY5Y cells at 43°C for 30 minutes with a water bath and 
subsequently culturing these cells for 6 hours, similar to the protocol used in the present study.16 
These researchers found that heating at 46.5°C resulted in 50% viability, which is in good 
agreement with the results of our EHT experiments, and suggested a relationship between 
thermotolerance and the high expression levels of some heat shock proteins in SH-SY5Y 
neuroblastoma cells.16 
Cellular damage induced by thermotherapy.  
Exogenous hyperthermia (EHT). Figure 5 presents TEM and dual-beam (FIB-SEM) images 
of neuroblastoma cells exposed to EHT hyperthermia treatment at temperatures of 46 (Figure 
5B) and 52°C (Figure 5C) for 30 minutes. Compared with the untreated control cells, the cells 
exposed to hyperthermia typically exhibited complete vacuolization of all organelles in the 
cytosol, including mitochondria and the endoplasmic reticulum, and a marked rupture of the 
plasma membrane (Figure 5A). These cell features indicative of necrosis were more evident in 
the cells exposed to 52°C (Figure 5C), and the cells subjected to EHT presented a clear change in 
their external morphology, which presented a rough surface and a collapsed appearance. 
Using a dual-beam (FIB-SEM) microscope, a series of cross-sectional images (Figures 5D-5F) 
of cells subjected to EHT at 52°C for 30 minutes showed a “deflated balloon” morphology and a 
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holey membrane. Consistent with the previous discussion, evident cytoplasmic vacuolation and 
irregularly shaped nuclei were observed in all analyzed samples. 
 
Figure 5. Electron micrographs of SH-SY5Y cells after EHT for 30 minutes: A) TEM image of 
control cell with typical cytological structure; B and C) TEM images of cells after EHT at 46°C 
(B) and 52°C (C). Note the intracellular vacuolation and the discontinuity of the cytoplasmic 
membrane related to membrane permeabilization. D) SEM micrograph showing the surface of a 
single cell after EHT at 52°C. Large membrane invaginations were observed (E), and cell cross-
sectional images obtained with SEM-FIB confirmed vacuolation and cytoplasmic damage (F). 
Magnetic hyperthermia (MHT). Neuroblastoma cells exposed to MHT were also 
morphologically characterized by TEM and dual-beam FIB-SEM (Figure 6). The control cells 
exposed to AMF (570 kHz and 23.9 kA/m) for 30 minutes (Figure 6A) presented no detectable 
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morphological changes. These micrographs confirmed that the exposure of cells to AMF in the 
absence of PEI-MNPs does not produce significant cell damage under our experimental 
conditions. An analysis of the subcellular organization of these cells revealed well-recognizable 
organelles in the cytosol, with an endoplasmic reticulum and mitochondria that were easily 
identifiable, as well as an intact cell membrane and nuclear envelope. Similarly, the cells 
incubated with PEI-MNPs also exhibited a healthy appearance and displayed visible MNPs 
grouped inside small membranes and free in the cytosol. In contrast, the cells exposed to MHT at 
46°C (Figure 6B and 6C) displayed abnormal membranous stacking dispersed in the cytosol 
accompanied by cell rounding and a surface membrane with irregular blebbing shapes, which is 
typical of apoptosis. Interestingly, these features were accompanied by a relatively well-
preserved nucleus and an intact cell membrane in most instances. The observed morphologies of 
the intracellular organelles and cytoplasmic structures were consistent with previous reports.17,21 
Overall, these morphological features suggest cell death by apoptosis.22 However, some cells 
also presented several crater-like membrane pores (Figure 6D and 6E) with a diameter of 
approximately one micron. The absence of PEI-MNPs attached to the cell surface in the majority 
of the SEM images recorded after MHT led us to hypothesize that these pores could have been 
caused by particles that were attached to the cell surface during the MHT treatment. We believe 
that at a temperature of 52°C, the presence of MNPs on the cell surface could have induced a 
surface heating process that enhanced membrane fluidly and exerted a generalized intracellular 
membranous wrecking effect. Our analysis of STEM images (SI, Figure S4) supported these 
results.  
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Figure 6. TEM and FIB-SEM micrographs of SH-SY5Y cells subjected to MHT for 30 minutes. 
A) Control cell (AMF, no particles). After MHT at 46°C (B) and 52°C (C), the PEI-MNPs (100 
g/mL) were still easily identifiable within the cytoplasm inside membranous structures. Dual-
beam FIB-SEM images after MHT at 46°C (D) show drastic changes in cellular roughness and 
numerous holes (arrows) and apoptotic blebs on the cytoplasmic membrane (E) and the 
cytoplasm (F). The scale bars are 2 m, except in (F) (5 m). 
As in the case of the EHT experiments, a negligible fraction of PEI-MNP clusters were found 
attached to the cell membranes after MHT. The cellular surface displays typical round blebs, 
suggesting cell death by apoptosis (Figures 6D-6F, white arrows). These blebs exhibited no Fe 
signal, as determined through a local EDX spectra analysis (not shown). Most of the population 
of cells subjected to MHT at 52°C lost their typical round shape and display the typical blebbing 
of apoptotic cells.  
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To obtain a complementary overall picture of the intracellular damage induced by MHT, a 
sample of SH-SY5Y cells treated with MHT at 52°C was dehydrated, contrasted and embedded 
in epoxy resin to perform a three-dimensional reconstruction from 25-nm-thick cross-sections 
produced by FIB-SEM. The cellular damage identified from these images and the 3D 
reconstruction (SI, Figure S5 and video file) extends across the complete cytoplasmatic 
compartment, and consistent with the above-described results, the distribution of PEI-MNPs 
after MHT showed that large fractions of these particles were expulsed to the extracellular 
medium during hyperthermia. The obtained cell ultrastructure showed apparent cytoplasmic 
cavities and vacuoles surrounded by a damaged cytoplasmic membrane.  
It is clear that both heating treatments (EHT and MHT) produced significant thermal damage. 
However, the cytotoxic effects observed in the MHT-treated neuroblastoma cells were more 
severe at lower temperatures (T < 42°C). After EHT hyperthermia at these temperatures, cell 
damage was negligible. Because PEI-MNPs interact strongly with the membrane,23 we believe 
that membrane-attached clusters could have exerted local heat-damaging effects in the 
membrane, producing the membrane pores observed after MHT and triggering necrosis. The 
ostensibly undisrupted nuclear membrane observed after both treatments might be due to the 
resistant nuclear membrane cytoskeleton, which assembles through the crosslinking of some 
intermediate nanometric filaments known as nuclear laminas. These protein networks further 
support and might preserve the lipid bilayer of the nuclear membrane from disorganizing after 
the heat shock treatments.  
Previous studies have illustrated the confinement of MNPs into endo-lysosomes by TEM24 or 
fluorescence confocal microscopy,25 demonstrating the influence of this confinement on the cell 
death mechanism experienced by the cultured cells subjected to AMF. Similarly, Asin et al. 
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showed that cell death can be triggered during MHT treatment by the release of countless 
proteases from the destructed lysosomes into the surrounding cell space.24 In addition, Creixell et 
al. demonstrated that the action of AMF activates the lysosomal death pathways in cancer cells 
overexpressing the EGFR.26 These results suggest that MHT treatments can produce at least two 
different -and complementary- cell death mechanisms resulting from the actual temperature 
effect in combination with the effect of (endo)lysosomal destruction. Additionally, Di Corato et 
al.27 performed in vitro and in vivo experiments using double-functional (photodynamic and 
magnetic) liposomes as therapeutic agents and found striking and very promising results 
regarding complete solid-tumor ablation in a rodent model. These liposomes were primarily 
located in the plasma membrane at the initial stage and were subsequently internalized within 
endosomal compartments. Both photodynamic and magnetic mechanisms are required for 
complete tumor ablation, although only the sub-lethal target temperatures (approximately 40°C) 
selected for this study could be the origin of the difference between the MHT-alone and dual-
modality protocols. Our results, although restricted to in vitro experiments, showed that a single 
MHT modality could be sufficient for complete cell death if the target temperature is adapted to 
the actual hyperthermia range of 42-45°C. Ogden et al.28 reported a comparative study between 
MHT and EHT cytotoxicity and demonstrated that the magnetic treatments presented greater 
effectiveness. This result is not in agreement with the results presented by Jordan et al.17 and 
Chan et al.,29 who detected no differences between the two hyperthermic approaches. Similarly, 
Wilhelm et al.30 evaluated the cytotoxic effects induced by EHT and MHT heating for 1 hour, 
and their results demonstrate that local MHT was as effective as global EHT and suggests a 
future optimization of the MNP design to improve the heating efficacy.  
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Our interpretation of the results obtained in the present study is in agreement with that reported 
by Ogden et al.28: MHT is more effective than global heating by EHT because MHT treatment 
for 30 minutes activates the late apoptosis-necrosis death process. In addition, our nano-heaters 
(PEI-MNPs) effectively destroyed these ‘micro-tumor-like’ pellets, which are smaller than those 
previously reported by Wilhelm and co-workers (2x107 cells).30,31 Baba et al.32 reported 
differences between superparamagnetic and ferromagnetic particles designed to treat MCF-7 
human breast cancer cells and found that ferromagnetic materials exposed to 250 kHz and 4 kW 
exhibited a higher heating efficiency. Unfortunately, the indication of the power available when 
performing an AMF experiment is not sufficient to determine the actual magnetic field amplitude 
delivered; thus, a comparison with our results is not straightforward. The cell death percentages 
observed when the temperature reached 46.4 and 48.5°C were 50 and 95%, respectively,32 which 
are similar to the range of temperatures obtained with our EHT experiments. The mortalities 
obtained with our in vitro MHT results, which were obtained with an application time of 30 
minutes, are in the same range as those observed at 43°C by Guardia et al.,21 who found 
approximately 50% mortality after 1 hour of treatment (110 kHz and 20 kA/m) and the induction 
of necrotic damage in KB cells. Yoo et al.33 reported the effect of magnetic hyperthermia 
treatment on breast cancer cells (MDA-MB-231) incubated with 200 µg/mL MNPs. These cells 
were irradiated at 500 kHz and 37.4 kA/m at a temperature of 43°C for 60 minutes. The resulting 
viability was 75%, which is lower than that observed in our study, and their SPA value was 471 
W/g, which is higher than the SPA of our PEI-MNPs.  
CONCLUSIONS 
Through a systematic series of in vitro studies, we compared the different effects that EHT and 
MHT heating protocols have on cell viability in similar ‘micro-tumor-like’ environments. We 
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obtained solid evidence that MHT requires lower target temperatures (approximately 6°C lower) 
to produce the same cell death effect as the EHT protocol, demonstrating the MHT protocol’s 
effectiveness and potential to remotely destroy tumor cells. The MNPs selected for these 
experiments showed good efficiency for heating these small-volume tumor-phantoms by AMF. 
Compared with EHT, the cytotoxic effects of MHT were more significant and occurred at lower 
temperatures. Although the morphological effects suggest that similar cell death pathways are 
induced by EHT and MHT, in the latter case, the rapid permeabilization and destruction of the 
cell membrane due to heating by the attached MNP clusters could add to the overall mechanisms 
induced by the temperature treatment. This study demonstrates how nano-heaters can destroy not 
just cultures of heat-stress-resistant neuroblastoma cells but also solid masses of neuroblastoma 
cells, which are comparable to micro-tumors and similar to those cells that initiate tumoral 
growth after metastasis in vivo. Taking into account (i) that magnetic particles are reasonably 
biocompatible and (ii) that this tumor type is typically characterized by a high degree of 
metastasis, the future use of nano-heaters could be a major advancement in the treatment of this 
still incurable pathology. The low target temperature required to kill 50% of the cell population 
using the MHT protocol, T0 = 42.1°C, is a very promising result, indicating the possibility that it 
could be developed into therapeutic protocols in clinical oncology.  
METHODS 
Synthesis of PEI-MNPs. PEI-MNP colloids were synthetized using a modified oxidative 
hydrolysis method, i.e., precipitation of an iron salt (FeSO4) in basic media (NaOH) with a mild 
oxidant.34 The method was modified to produce an in situ polymer coating with 25-kDa 
polyethylenimine (PEI) during the reaction to obtain PEI-coated MNPs. The process for 
synthesizing the water-based magnetic colloid has been reported elsewhere.23,35  
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Cell culture and compacted pellet conditions. Human neuroblastoma SH-SY5Y cells 
(ATCC CRL-2266) were cultured in Dulbecco’s Modified Eagle’s Medium and Ham’s F12 (1:1) 
with 15% fetal bovine serum, 100 IU/mL penicillin, 100 μg/mL streptomycin and 2 mM L-
glutamine. The cells were maintained at 37°C in a saturated humidity atmosphere containing 
95% air and 5% CO2. To reduce the intrinsic biological variability and standardize the treatment 
conditions, we developed a neuroblastoma cell phantom that mimics some very basic conditions 
of a micro-tumor environment with the aim of emulating in vivo treatment experiments. Cellular 
pellets composed of approximately 6-7x106 neuroblastoma cells immersed in 100 µL of protein-
rich culture medium were treated inside PCR microcentrifuge tubes. 
Exogenous hyperthermia treatment. Exogenous hyperthermia was performed using a water 
bath (Medingen Labortechnik MWB5). Cells (1x106 cells/well) were seeded in a six-well plate in 
2 mL of culture medium and incubated for two days to reach the exponential growth phase. The 
cells were washed in PBS, detached and resuspended in 100 µL of supplemented DMEM. The 
samples were exposed to different temperatures (37 to 56°C) by immersion in a water bath for 30 
minutes and then cultured for an additional 6 hours. To observe the long-term effects of the 
hyperthermia treatment, the viabilities of the cells were calculated immediately after the 
treatment and after re-culture using the trypan blue (TB) exclusion protocol. 
Magnetic hyperthermia treatment. Magnetic hyperthermia (MHT) experiments were 
performed using a commercial DM-1 applicator (nB Nanoscale Biomagnetics S.L., Spain) with 
constant target-temperature programs, which are applicable for different time periods. The set 
point was reached asymptotically from room temperature, with very small overheating values (< 
1°C). The heating rates and set point temperatures were maintained through feedback-based 
controlled field amplitude modulation (SI, Figure S6). The experiments were performed at 570 
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kHz, and the magnetic field amplitudes were varied in the range of 3.98 ≤ H ≤ 23.9 kA/m to 
maintain the target temperature. A predefined number of starting cells (1x106 cells/well) were 
seeded in a six-well plate in 2 mL of complete culture medium. The next day, the culture 
medium was replaced with PEI-MNPs (100 µg/mL) dispersed in supplemented DMEM, and the 
plate was incubated for 24 hours. After this incubation time, the cells were washed in PBS, 
detached and resuspended in 100 µL of supplemented DMEM. Compacted cell pellets incubated 
with PEI-MNPs were placed in DM-1 for 30 minutes and were then cultured for 6 hours. The 
cell viability was determined using the same protocol that was used with the EHT-treated cells. 
Transmission electron microscopy (TEM). Samples were prepared by seeding cells (1x106 
cells/well) in a six-well plate in 2 mL of culture medium. Twenty-four hours after plating, MNPs 
at a concentration of 100 µg/mL were added to the culture. After overnight incubation, the cells 
were detached and exposed to temperatures of 46 and 52°C for 30 min using both the EHT and 
MHT heating approaches. Cell samples were fixed with 2% glutaraldehyde for 2 hours at 4°C, 
treated with 2.5% potassium ferrocyanate and 1% osmium tetroxide, dehydrated and embedded 
in epoxy resin. Ultrathin sections of slices (70 nm) were cut and observed in a FEI Tecnai F30 
microscope operated at an accelerating voltage of 300 kV. The images in STEM-HAADF mode 
were obtained using a HAADF (high-angle annular dark field) detector for the STEM mode and 
an EDX (energy-dispersive X-ray) spectrometer.  
Dual-beam (FIB-SEM) analysis. The intracellular distribution of MNPs in conditioned SH-
SY5Y neuroblastoma samples was analyzed using a dual-beam FIB-SEM (Nova 200 NanoLab, 
FEI Company). SEM images were recorded at 5 and 30 kV using a FEG column. A combined 
Ga-based 30-kV (10-pA) ion beam was used to cross-section single cells. Dehydrated cells on 
coverslips were coated with platinum for FIB-SEM imaging. The cell sections embedded in 
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epoxy resin used for the TEM observations were also investigated using a dual-beam Helios 650 
instrument from FEI Company, which was operated in the “slide and view” mode using 30 kV 
(0.43 nA) for the ion beam, and BSE images were acquired at 2 kV and 0.2 nA using the TLD 
detector in the immersion mode. 3D reconstruction images were processed using Amira 
software. 
Confocal microscopy imaging. PEI-MNPs were functionalized with Alexa 488, which is 
suited to the 488-nm laser line. First, PEI-MNPs were suspended in 1 mL of 0.1 M sodium 
carbonate-bicarbonate buffer at pH 9.5 to ensure deprotonation of the amine groups of the PEI 
polymer coating.36 Alexa 488 solution (1 mg·mL-1 DMSO: 20 µL) was then added to the 
suspension of PEI-MNPs, and the reaction mixture was covered with foil and rotated at room 
temperature for 3 hours. The final Alexa 488-functionalized PEI-MNPs were washed with 
deionized water until no further fluorescence was observed in the supernatant. These particles are 
henceforth denoted as f-PEI-MNPs. Following incubation with the particles, cells were exposed 
to both types of heating treatments (EHT and MHT) and then immediately fixed in 4% 
paraformaldehyde. Staining of cell actin was performed using phalloidin-tetramethylrhodamine 
B isothiocyanate (Sigma-Aldrich), and DNA (nucleus and chromosomes) was stained using 
Hoechst dye (bisbenzimide) (Sigma-Aldrich). Confocal microscopy images were obtained using 
a Nikon A1R confocal microscope and processed with NIS-Elements Advanced Research 
software. All confocal cell images were pseudocolored. Ethidium bromide staining was 
performed for necrosis determination.  
Quantitative/qualitative flow cytometry determination of apoptosis and necrosis. An 
average of 10,000 cells per condition were analyzed by flow cytometry using a FACS Aria 
Cytometer. The data were analyzed using FACS Diva software (Becton Dickinson, NJ, USA). A 
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quantitative analysis of cell death by apoptosis and necrosis was performed using a commercial 
kit (Annexin V FITC kit, Immunostep, Spain) that can discriminate live cells from those in the 
early or late phases of apoptosis or necrosis. Three cell populations were detected: (i) unstained 
cells, representing viable cells, (ii) Annexin V (+) / PI (-) cells, representing early apoptotic cells, 
and (iii) Annexin V (+) / PI (+) cells, representing late apoptotic or necrotic cells. Early necrosis 
was determined through membrane permeabilization assays complemented with confocal and 
electron microscopy examinations. 
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